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Abstract
Cryptococcosis causes approximately 180 000 deaths each year in patients with human immunodeficiency
virus (HIV). Patients with other forms of immunosuppression are also at risk, and disease is increasingly
recognized in apparently immunocompetent individuals. Cryptococcus neoformans var. grubii, responsible
for the majority of cases, is distributed globally. We used the consensus ISHAM Multilocus sequence typing
(MLST) scheme to define the population structure of clinicalC. neoformans var. grubii isolates from Laos (n=
81), whichwe placed into the global context using publishedMLST data fromother countries (total N= 1047),
including a reanalysis of 136 Vietnamese isolates previously reported. We observed a phylogeographical
relationship in which the Laotian population was similar to its neighbor Thailand, being dominated (83%) by
Sequence Types (ST) 4 and 6. This phylogeographical structure changed moving eastwards, with Vietnam’s
population consisting of an admixture of isolates dominated by the ST4/ST6 (35%) and ST5 (48%) lineages.
The ST5 lineage is the predominant ST reported from China and East Asia, where it accounts for >90%
of isolates. Analysis of genetic distance (Fst) between different populations of C. neoformans var. grubii
supports this intermediate structure of the Vietnamese population. The pathogen and host diversity reported
from Vietnam provide the strongest epidemiological evidence of the association between ST5 and HIV-
uninfected patients. Regional anthropological genetic distances suggest diversity in the C. neoformans var.
grubii population across Southeast Asia is driven by ecological rather than human host factors. Where the
ST5 lineage is present, disease in HIV-uninfected patients is to be expected.
Key words: Cryptococcus neoformans, multilocus sequence typing, Laos, Vietnam, population structure.
Introduction
Cryptococcus neoformans is the main etiological agent of
cryptococcosis. It is of major significance in patients infected
with human immunodeficiency virus (HIV), accounting for an
estimated 223 100 cases of meningitis per year globally, and
in other individuals with immunosuppression.1 C. neoformans
is an environmental saprophyte associated with bird guano
and trees.2–5 There is no human to human spread, and human
C© The Author(s) 2018. Published by Oxford University Press on behalf of The International Society for Human and Ani-
mal Mycology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium,
provided the original work is properly cited.
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infection is believed to result from the inhalation of either
desiccated yeasts or spores.6 In Asia, the majority of cases of
cryptococcal meningitis are due toC. neoformans var. grubii.7–10
Here, in addition to the strong association with HIV infection,
C. neoformans var. grubii is also reported to cause disease in ap-
parently healthy individuals.11,12 Such cases have been reported
from China, Japan, Korea, and Vietnam and are typically asso-
ciated with a clonal group known as VNI-gamma or ST5.7,13–16
The clinical and environmental C. neoformans var. grubii
isolates from South, East and Southeast Asia exhibit a clonal
population structure.17,18 Multilocus sequence typing (MLST)
epidemiological studies from East Asia have shown limited ge-
netic diversity among the majority of environmental and clinical
isolates.13,19,20 Different geographical areas have distinct pop-
ulation structures, particularly in relation to the predominant
sequence types.17 Previous studies suggested that though in rela-
tively close geographical proximity, the population structure of
C. neoformans var. grubii from Thailand and China are signifi-
cantly different.21,22 We recently reported the population struc-
ture of C. neoformans var. grubii from Vietnam,23 but analyses
focused on associations between clinical features and popula-
tion structure. Here we present novel data from Laos and novel
analyses of our previously published Vietnamese data set.
Our specific goals were (i) to describe the genetic structure of
the Laotian C. neoformans var. grubii population using MLST,
and (ii) to set the Vietnamese and Laotian populations within
the global context.
Methods
Ethics statement
All studies from which samples were derived were approved by
the relevant institutional review board: the Hospital for Tropical
Diseases Ethical Review Board, Ho Chi Minh City, the National
Ethics Committee for Health Research Vietnam, the Ministry
of Health, Lao People’s Democratic Republic, and either the
Oxford Tropical Ethics Committee, University of Oxford, or the
Ethics Committee of the Liverpool School of Tropical Medicine.
All patients were adults and gave written informed consent to
enter the clinical studies. Where the patient lacked capacity to
consent through illness, the written consent of the responsible
next of kin was obtained. All clinical data and samples were
anonymized.
Patients and isolates
The Vietnamese isolates (total n = 136) included in this study
were clinical isolates from the cerebrospinal fluid (CSF) of pa-
tients enrolled in a randomized controlled trial of antifungal
therapy in HIV-infected patients (n = 98) between 2004 and
2011, and a prospective, descriptive study of HIV-uninfected
patients with central nervous system (CNS) infections (n = 38)
enrolled between 1998 and 2009.7,18 The Laotian isolates were
from 81 patients with cryptococcal meningitis (67 HIV-infected,
8 HIV-uninfected, and 6 with unknown HIV status) consecu-
tively admitted to Mahosot and associated hospitals in Vien-
tiane, between 2003 and 2015.
DNA extraction and restriction fragment length
polymorphism (RFLP) analysis
Total genomic DNA was extracted from all organisms using the
Masterpure Yeast DNA kit (Epicentre Biotechnologies, Madi-
son, WI, USA) according to the manufacturer’s instructions. Re-
striction fragment length polymorphism analysis (RFLP) of the
orotidine monophosphate pyrophosphorylase (URA5) gene was
used to confirm species/varietal status of all C. neoformans var.
grubii isolates.24 Polymerase chain reaction (PCR) of the URA5
gene was conducted in a final volume of 50 μl. Each reaction
contained 50 ng of DNA, 1X HotStart PCR buffer (NEB, USA),
0.2 mM each of dATP, dCTP, dGTP, and dTTP (Roche Diagnos-
tics GmbH), 2mMmagnesium acetate, 0.5 UHotStart TaqDNA
polymerase (NEB, USA), and 0.15 μM of each primer URA5
(5′- ATG TCC TCC CAA GCC CTC GAC TCC G - 3′) and S01
(5′- TTA AGA CCT CTG AAC ACC GTA CTC - 3′). PCR was
performed in a Nexus SX1 thermal cycler (Eppendorf, USA) at
95◦C for 15 min, followed by 35 cycles of 20 s denaturation
at 94◦C, 40 s annealing at 61◦C, and 1 min extension at 72◦C,
followed by a final extension cycle for 3 min at 72◦C. In sum, 10
μl of PCR products were double digested with Sau96I (0.2 U/μl)
and HhaI (0.8 U/μl) for 3 h at 37oC, followed by a final 10 min
incubation at 60oC. Restriction products are separated by 3%
agarose gel electrophoresis at 100 V for 5 h. RFLP patterns were
assigned visually by comparing them with the patterns obtained
from the control strains (VNI-VNIV and VGI-VGIV; see Sup-
plementary Table S1) kindly provided by Prof. Wieland Meyer,
University of Sydney.
Multilocus sequence typing (MLST)
Seven MLST loci (CAP59, GPD1, IGS1, LAC1, PLB1, SOD1,
and URA5) were amplified and sequenced following the pro-
cedures of the International Society for Human and Animal
Mycology (ISHAM) MLST consensus typing scheme for C. ne-
oformans (http://mlst.mycologylab.org).25 Sequencing was per-
formed using BigDye v3.1 Chemistry (Applied Biosystems, CA,
USA) on an ABI 3130 Genetic Analyzer (Applied Biosystems,
CA, USA). Both forward and reverse amplicons of each locus
were sequenced. Consensus sequences were manually edited us-
ing ContigExpress and aligned in AlignX, implemented in Vec-
torNTI Suite 7.0.26 A single Allele Type (AT) number was as-
signed to each of the seven loci by comparing consensus DNA
sequenceswith the ISHAMdatabase, resulting in a seven-number
allelic profile for each isolate. The allelic profiles defined the cor-
responding STs.
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MLST profiles and DNA sequences at each MLST loci for
isolates from regions other than Laos and Vietnam were ob-
tained fromNCBI. For the global analysis, we used data reported
by Simwami et al.,21 Mihara et al.,14 and Cogliati et al.27 in-
cluded in Khayhan et al.,17 and from Chen et al.,28 Ferreira-Paim
et al.,29 Beale et al.,30 and Dou et al.31
Phylogenetic analyses
For global comparison, information on MLST genotypes, pa-
tient HIV status, and source of isolation for 1047 isolates from
other countries were obtained from NCBI.14,17,21,27,28 These
consisted of clinical and environmental C. neoformans var. gru-
bii isolates from Southeast Asia (Indonesia, Thailand, Vietnam);
East Asia (Japan, China, South Korea); South Asia (India), Mid-
dle East (Qatar, Kuwait); North America (USA); South America
(Brazil, Argentina); Europe (Germany, Italy, France, Belgium);
Australasia (Australia), and Africa (Botswana, Malawi, Tanza-
nia, Uganda, Zaire, South Africa). Further details of the isolates
and corresponding patient information are presented in supple-
mentary Table S1.
First, we determined the best DNA substitution model for
the concatenated dataset using MEGA v6.0.6.32 The Kimura
two-parameters model with gamma distribution was selected
as the best-fit model using the Bayesian information criteria
(BIC) calculated with MEGA v6.0.6.32 To evaluate patterns
of evolutionary descent among genotypes according to their
source and geographic region, the allelic profile of the Viet-
namese, Laos, and global data set were applied to the goe-
BURST algorithm in PHYLOVIZ 2.0 software available at
http://www.phyloviz.net.33,34 A group founder was defined as
the sequence type with the most number of linked single lo-
cus variants (SLV). The concept of a clonal complex (CC) was
adopted when a SLV linkage with the founder ST was observed.
Multidimensional (MDS) clustering
Genetic distance (Fst) and geographical distance were visualized
by the nonmetric multidimensional scaling method. Fst were
calculated from concatenated sequences of the seven MLST
housekeeping genes using DnaSP v5.35 MDS calculation was
performed using RStudio Version 0.98.1103 built with R-3.4.0
(https://www.rstudio.com and https://www.r-project.org). Net-
work analysis and visualization was conducted using the R pack-
age igraph (version 1.1.2).
Results
MLST reveals dominance of ST4 and ST6 sequence
types in Laos
All 81 Laotian isolates belonged to the RFLP-defined VNI group.
Among them, ST4 and ST6 accounted for over 40% each of the
total number of isolates, and were 4-fold more prevalent than
ST5; (ST4, n = 35 (43%); ST6, n = 33 (41%); ST5, n = 9 (11%),
Fig. 1A, Table 1). Less than 3% of isolates from Laos (n = 2)
were ST93. This contrasted with its adjacent neighbor, Vietnam
(N = 136), where ST5 predominated (n = 66; 48%), followed
by ST4 (n = 32; 24%), ST93 ( = 8; 6%), and ST6 (n = 12; 9%).
Correlation between infection with ST5 and HIV status
Isolates of ST5 have previously been reported to be asso-
ciated with HIV-uninfected patients in East Asia and Viet-
nam.7,14,18,19,36 Most cases of cryptococcal meningitis in Laos
were associated with HIV infection. The ST5 lineage accounted
for just 9% (6 of 67) of infections in HIV-infected patients, sug-
gesting a relatively low prevalence in the environment. Of eight
cases of meningitis in Laos in HIV-uninfected patients, two were
due to ST5 isolates (odds ratio 3.39 [95% confidence interval
{CI}: 0.56 to 20.64], P = .18, Fisher exact test). HIV serostatus
was not known for the remaining six patients.
To increase the power to test an association between ST5 iso-
lates and HIV infection, we gathered previously described data
from Asia, Europe, South America, and Africa on lineage and
patient HIV serostatus.17,23,28,30 Clinical isolates with unknown
HIV status were excluded from the analysis. Of 194 HIV unin-
fected patients, 136 (70%) were infected with ST5 isolates; of
791 HIV infected patients, 117 (15%) were infected with ST5
isolates (odds ratio 13.51 [95% CI: 9.38 to 19.45], P < .0001,
Fisher exact test). There were 296 clinical or environmental ST5
isolates in the dataset; East and Southeast Asia accounted for
the majority of these (n = 153 [51%] and n = 104 [35%], re-
spectively). Here, the relative proportion of ST5 isolates from
each country decreased along a clockwise arc from Northeast to
Southwest: Japan (n = 36; 86%, 95% CI: [72–94]), China (n =
116; 86%, 95% CI: [80–92]), Vietnam (n = 66; 48%, 95% CI:
[40–57]), Thailand (n = 29; 13%, 95% CI: [9–18]) and Laos (n
= 9; 11%, 95% CI: [5–20]). ST5 accounted for 20% (n = 2)
and 40% (n = 2) of the total number of isolates from Kuwait
and Qatar in the Middle East, respectively.
The majority of cases of disease in apparently immunocom-
petent, HIV-uninfected patients were from East and Southeast
Asia. ST5 has been reported from elsewhere, including Brazil
(n = 3; 2%, 95% CI: [5–7]), South Africa (n = 27; 15%, 95%
CI: [10–22]), Uganda (n= 1; 6%, 95%CI: [0–30]) and Botswana
(n = 1; 0.7%, 95% CI: [0.0–3.7]), but in these regions disease
in HIV-uninfected patients due to the type has rarely been re-
ported.28–30
GoeBurst analysis and geographical distribution
We used the previously published data to elucidate how the
Laotian and Vietnamese populations fit in the wider global
context.17,20,28–30 GoeBurst analysis placed C. neoformans var.
grubii isolates from Vietnam and Laos, along with those from
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Figure 1. goeBurst analysis integrating the Laotian and Vietnamese C. neoformans var. grubii isolates into the major Asian clonal complex. Minimum spanning
tree showing the major Asian clonal complexes (lineages). (A) Laos and Vietnam as part of the global population. The main subgroups of the major clonal
complex are indicated by circles. (B) The major clonal complex broken down into geographical regions: East Asia (China and Japan), Southeast Asia (Vietnam,
Laos, Thailand and Indonesia), South Asia (India), plus the reference groups Middle East (Qatar and Kuwait), Europe, North/South America and Africa. The
number in the center of each circle indicates the ST of those isolates.
all other Asian, North/South American, Middle Eastern, and
African countries in a clonal complex (Fig. 1A and B). The main
clonal complex included three main goeBurst subgroups derived
from ST174; subgroup 63 (ST63), subgroup 4 (ST4/ST6), sub-
group 5 (ST5), and subgroup 31 (ST31/ST32/ST93) (Fig. 1A).
Subgroup 63 was a double locus variant (DLV) from ST174 and
was more distant to the other three subgroups. While most South
African and Ugandan isolates were included in the main clonal
complex, the bulk of isolates from Botswana were separated
from the major clonal complex by at least 5 SLVs. ST174 was
placed at the center of the clonal complex and was identified as
a potential group founder of the clonal complex when analyzed
by both parsimony (Fig. 1B) and maximum likelihood analyses
(Fig. S1).
We observed an association between geographical location
and STs (Fig. 1B). Most Asian isolates were included in sub-
group 4 and subgroup 5, while isolates from other regions were
widely distributed across the clonal complex. Subgroup 63 in-
cluded European, North/South American, African, as well as a
few East Asian isolates, but none from Southeast Asia. While
subgroup 4 was reported from other continents, it was highly
prevalent in Southeast Asia (n = 317, 66% of all Southeast
Asian isolates (total N = 479)). Isolates from sub-group 5 had
a wide distribution but in different proportions depending on
the geographical regions: the Middle East (n = 4; 33% [regional
total N = 15]), Africa (n = 33; 10% [regional total N = 346]),
Europe (n = 5; 13% [regional total N = 39]), North America
(n = 1; 11% [regional total N = 9]), South America (n = 3;
2% [regional total N = 133]), Southeast Asia (n = 105; 22%
[regional total N = 479]) and most notably from East Asia (n =
158; 88% [regional total N = 180]). Similarly, subgroup 31 was
also widely distributed but was most prevalent in South America
(n = 110; 83% [regional total N = 133]) and South Asia (n =
53; 85% [regional total N = 62]). Other regions with subgroup
31 populations included Africa (n = 86; 25% [regional total N
= 346]), the Middle East (n = 4; 27% [regional total N = 15]),
North America (n = 3; 33% [regional total N = 9]), Europe (n
= 6; 15% [regional total N = 39]). Subgroup 31 was much less
common in East Asia (n = 6; 3% [regional total N = 180]) and
Southeast Asia (n = 52; 11% [regional total N = 479]).
Genetic distance between C. neoformans populations
from different geographical regions
We employed the fixation index (Fst) to evaluate pairwise
genetic differentiation between different geographical regions.
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Table 1. Distribution of major Sequence Types (ST) in the Asia/Middle East region according to country of origin and HIV status.
Sequence Type (ST)∗
Country
HIV status 4 5 6 31 32 39 53 69 93 174 177 187 188 194 195 306
China 104 1 5 1 2 1
HIV(−) 80 1 4 1 1
HIV(+) 24 1 1 1
India 1 2 7 28 3 1 1
HIV(−) 1 4 6 2 1 1
HIV(+) 2 3 22 1
Indonesia 8 10 2 16 3
HIV(−) 1
HIV(+) 8 10 2 16 2
Japan 20
HIV(−) 20
HIV(+)
Kuwait 1 2 1 1 1
HIV(−) 2 1 1
HIV(+) 1 1
Laos 32 8 32 1 1 1
HIV(−) 3 2 2 1
HIV(+) 29 6 30 1 1
Qatar 1 2 2
HIV(−) 1 2
HIV(+) 1 1
Thailand 64 20 57 3
HIV(−) 2 1
HIV(+) 62 20 57 2
Vietnam 32 66 12 7 3 8 2 1 1
HIV(−) 3 31 1 2 1
HIV(+) 29 35 11 5 3 8 2 1
Total 139 222 113 10 7 3 5 3 58 4 4 2 2 2 2 2
Numbers within cells are the number of isolates of that ST from that country. HIV, human immunodeficiency virus.
∗Any minor sequence type with only one isolate was excluded from this table
Multidimensional scaling (MDS) was carried out to provide a
2-D visualization of the Fst distance matrix (Table 2 and Fig. 2).
Botswana, being structurally highly diverse, is in stark contrast
to other countries and therefore was removed from the analysis.
Furthermore, due to the apparent propensity of ST5 towards
HIV-uninfected patients, the Fst analysis only included isolates
from HIV-infected patients from Laos, Thailand, Vietnam, In-
donesia, China, India, South Africa. and Brazil. Very few iso-
lates from Japan, Korea, Kuwait, or Qatar were known to be
from HIV-infected patients. and thus isolates from these coun-
tries were also excluded from the analysis. In addition, isolates
from any countries with fewer than 20 isolates were also ex-
cluded on the grounds that it was difficult to be sure they were
representative of the country’s wider C. neoformans var. grubii
population.
The MDS plot revealed that the Indian C. neoformans var.
grubii population was most closely related to the Brazilian
population (Fst = 0.016), followed by the Indonesian popu-
lation (Fst = 0.155) and was more distant to other Southeast
Asian countries (Vietnam, Thailand, and Laos, Fst ranging from
0.304 to 0.676). Of the Southeast Asian populations, those
from Laos and Thailand were most genetically close (Fst =
0.002); the Indonesian population was most closely related to
the Vietnamese population (Fst = 0.077). The population from
Vietnam, while being placed closer to Indonesia in the MDS
analysis, appeared to be intermediate between China in East
Asia (Fst = 0.075) and Laos/Thailand in Southeast Asia (Fst
= 0.090 and Fst = 0.095, respectively). This is in spite of the
fact that both Vietnam and Laos share northern borders with
China (Fst = 0.424 between Laos and China). In fact, the Thai
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Table 2. Genetic distance matrix (Fst) of C. neoformans var. grubii populations by country.
Laos Indonesia Thailand India South Africa Vietnam Brazil China
Laos 0 0.263 0.002 0.676 0.158 0.09 0.62 0.424
Indonesia 0 0.245 0.155 0.029 0.077 0.146 0.285
Thailand 0 0.605 0.205 0.095 0.632 0.28
India 0 0.112 0.304 0.016 0.635
South Africa 0 0.068 0.156 0.086
Vietnam 0 0.362 0.075
Brazil 0 0.495
China 0
Laos
Indonesia
Thailand
India
South Africa
Vietnam
Brazil
China
Figure 2. Mutidimensional scaling plot of genetic distances (Fst) of global C.
neoformans var. grubii isolates from HIV-infected patients. Vietnam appeared
to represent an intermediate population between that from Laos/Thailand
and that from China. Among Southeast Asian populations, that of Indonesia
is most similar with the Indian population, possibly due to the uniquely high
proportion of ST93, a feature also shared by C. neoformans var. grubii from
India and Brazil. This Figure is reproduced in color in the online version of
Medical Mycology.
and Chinese populations appeared genetically closer than the
Laos-China populations (Fst = 0.280).
Discussion
The population structure of C. neoformans var. grubii has
been described for a number of Asian countries,17 including
Vietnam,23 Thailand,10,21 India,37 China,36,38–40 Japan,14 and
Korea.13 However, data from Laos have been lacking, and
Vietnamese data have not previously been placed into the global
context. To address this, we typed 81 isolates from Laos and
re-analyzed 136 previously published isolates from Vietnam
using MLST. A strength of our data set is that it contains signif-
icant numbers of strains from both HIV-infected and uninfected
patients. In contrast, reports from China and East Asian coun-
tries are dominated by clinical isolates from HIV-uninfected
patients, while studies from Thailand and other Southeast Asian
countries including Singapore41, Malaysia,42 and Indonesia43
present isolates predominantly from HIV-infected patients. The
differences between the immune statuses of patients sampled
in different countries complicate interpretation of the data but
also mean that Vietnam is in a unique position to demonstrate
the association between C. neoformans var. grubii ST5 and host
immune phenotype.
In China, ST5 is the dominant sequence type, accounting for
over 90% of infections.8,19,31 While it is present in both im-
munocompetent and immunocompromised patients, relatively
few cases of HIV-associated disease have been reported.31 The
reasons for this are unclear. While China has a relatively low
prevalence of HIV (estimated at <0.1% of the adult population
in 201544), given the size of its population the few cases of HIV-
associated disease reported may represent bias in study design,
HIV testing or research interests. However, a recent paper has
reported 35 cases of cryptococcosis in HIV infected people, of
which 33 were ST5. Overall, they reported that 73 of 86 patients
in their study were infected with ST5 isolates.45
In contrast to China, the C. neoformans var. grubii popula-
tion from Thailand appears more diverse according to MLST,
with 14 STs reported, among which ST4 and ST6 are most
common, outnumbering ST5 infections 6 to 1.10,17,21 We found
the population structure of isolates from Laos to be similar to
that in Thailand, with ST4 and ST6 (both belonging to subgroup
4) accounting for the majority of disease. This dominance of
a single sub-group in both Thailand/Laos and China contrasts
with Vietnam, where ST5, ST6, and ST4, belonging to two
separate sub-groups, are similarly prevalent. The Thai data are
notable for the lack of cryptococcal meningitis cases reported
from HIV-uninfected patients. It seems unlikely that this
represents underreporting of non-HIV associated disease which
is generally considered remarkable; rather, we hypothesize that
this reflects a low prevalence of ST5 isolates in the environment,
which is clearly associated with apparently immunocompetent
patients elsewhere in Asia.8,18,19,23,31 If the ST5 lineage was
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common in Thailand and Laos, we would expect to detect this
from reporting of disease in HIV infected patients; in Vietnam
it is responsible for >35% of cases of cryptococcal meningitis
in HIV-infected patients. Thus in Vietnam the Cryptococcus
population seems to represents an intermediate population be-
tween Laos/Thailand to the West, and China to the Northeast,
consistent with its geographical location.
Of note, Indonesia also appears to have two equally dominant
burst groups among clinical isolates. ST4/6 isolates account for
44%, of human infections, with ST93, common in East Africa
and also frequently reported from India, accounting for a further
44%.17
The differences in population structure we see moving from
west to east are likely driven by ecological and/or human fac-
tors. Ecological differences between the regions could select for
enrichment of particular STs if there are differences in the rel-
ative fitness of the STs in those niches. Southeast Asia is a ge-
ographically and ecologically diverse area known for its high
species density.46,47 The south of the region has a hot tropical
climate with dry and wet seasons; the north is temperate with
hot summers and cold winters. The Annamite mountain range,
covered in dense rain forests, rises to over 3000 meters and runs
the length of Vietnam, forming a barrier separating Thailand,
Laos, and Cambodia from Vietnam and southern China. There
are also significant differences in elevation (for example, Chiang
Mai, in Northern Thailand and the source of most published
Thai data, and Vientiane in Northwestern Laos are at signifi-
cantly higher elevation than Ho Chi Minh City and much of
Southeastern China (170–300 meters versus 10–20 meters above
sea level). Other than elevation and temperature, localized dif-
ferences in soil biogeochemistry, environmental predators such
as amoebae,48 and tree species may also be relevant. For ex-
ample, Laos, Cambodia, Vietnam, and China are among Asian
countries where there is significant contamination of groundwa-
ter with high levels of arsenite.49,50 Recently, it has been shown
that ST5 C. neoformans var. grubii isolates possess tandem re-
peats of the arsenite efflux transporter (Arr3).51 The greater the
number of these repeat elements the higher the resistance to toxic
arsenic containing compounds.51 Differences in the distribution
of this pollutant could correlate with the distribution of ST5.
Other human activities that could influence ecology or human
exposure to infection include irrigation, urbanization, and min-
ing, and human migration and international trade links could
influence dispersal of C. neoformans var. grubii lineages in Asia
and elsewhere.
In addition to ecological factors, the varying prevalence of
lineages in particular human populations could be a result of dif-
ferential host susceptibility to particular lineages. Such human
genetic factors have previously been associated with suscepti-
bility to tuberculosis.52 However, the dominant ethnic group in
Vietnam (Kinh, >80%) is genetically closer to ethnic groups in
Northern Thailand than to the Han Chinese from Beijing or
Southern China53 (also see Fig. S2). The differences between
the Thai and Vietnamese C. neoformans var. grubii populations
we demonstrated here suggest that the diversity of the pathogen
population is not driven by host susceptibility. Nevertheless, it
remains possible that subtle human genetic polymorphisms exist
that result in differential susceptibility to different cryptococcal
species/lineages.
Our observations augment the findings of Ferreira-Paim and
co-workers who suggest that the populations of C. neoformans
var. grubii found in many geographical regions across Asia and
the Middle East arose from ST174.29 The ST174 expansion
model is supported by goeBurst and maximum likelihood phy-
logeny analyses, which show it is the most parsimonious can-
didate as the group founder of subgroups 4, 5, and 31, which
account for over 90% of the Southeast Asian isolates. We did
not observe ST174 in either Vietnam or Laos, but it has been
present in previously published datasets from South Asia and the
Middle East, with three isolates from India and one isolate from
Kuwait17 and has also been reported from Germany in a patient
of Asian origin.54 The prevailing hypothesis with respect to the
evolution of CN, suggests that the current circulating Asia popu-
lation emerged “Out-of-Africa.”5 Our data neither confirm nor
support this hypothesis, rather showing that the extant popula-
tion of CN associated with human disease in Asia has descended
from a single common ancestor. Given the age of C. neofor-
mans as a species, and the fact that it is not primarily a human
pathogen, nor is it spread from person to person, it seems some-
what unlikely that its global distribution is driven by migration
of (latently or actively) infected humans. However, as described
earlier, other human factors may be relevant. The emergence of
the preponderance in most countries of strains of a single burst
group on a background of greater diversity, suggests different
fitness of different STs in particular ecological types.
Our study addressed the lack of knowledge of the molecular
epidemiology of C. neoformans var. grubii from Laos and place
previously generated data from Vietnam into a broader con-
text. We found a change in predominant STs as one moves from
western to eastern longitudes, that the Vietnamese C. neofor-
mans var. grubii population appears intermediate between Thai
and Chinese populations, and is unique in mainland Southeast
Asia for having a high prevalence of two subgroups. Our data
suggest that ST174 is the putative most recent common ancestor
for the majority of C. neoformans var. grubii sequence types in
Asia. The C. neoformans var. grubii population in Asia present
in this study appeared mostly clonal, which is similar to previous
reports.
Most studies focusing on VNI, including ours, are weak-
ened in that while cryptococcosis results from the inhalation
of infectious propagules from the environment, few environ-
mentally sourced isolates have been typed and thus the true
diversity of the species in any country may be underestimated.
More efficient environmental isolation techniques and systematic
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sampling would allow us to understand the true species diversity
by region and could improve understanding of the basis of cryp-
tococcal virulence as well as bottleneck events leading to the rise
of pathogenic lineages.
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Supplementary data are available at MMYCOL online.
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